Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1CNS 1

Conditions

Breast Neoplasms 970Neoplasms 767Carcinoma, Non-Small-Cell Lung 750Prostatic Neoplasms 577Colorectal Neoplasms 503Lung Neoplasms 447Neoplasm Metastasis 408Multiple Myeloma 376Leukemia, Myeloid, Acute 358Ovarian Neoplasms 311Pancreatic Neoplasms 306Melanoma 275Squamous Cell Carcinoma of Head and Neck 259Recurrence 248Carcinoma, Hepatocellular 233Glioblastoma 225Brain Neoplasms 221Head and Neck Neoplasms 202Triple Negative Breast Neoplasms 200Carcinoma, Renal Cell 200Lymphoma 192Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Stomach Neoplasms 189Endometrial Neoplasms 179Lymphoma, Non-Hodgkin 175Sarcoma 169Glioma 168Uterine Cervical Neoplasms 167Lymphoma, Large B-Cell, Diffuse 160Hematologic Neoplasms 159

Interventions

Sufentanil 1Electroacupuncture 1((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Postoperative Nausea and Vomiting × 90 days × Clear all
NCT07479446 2026-05-22

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

Xuanwu Hospital, Beijing

Phase NA Recruiting
174 enrolled
CNS

Neuroma, Acoustic, Postoperative Nausea and Vomiting

NCT07515027 2026-04-13

Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery

Shanghai Chest Hospital

Phase NA Recruiting
204 enrolled

Postoperative Nausea and Vomiting

NCT07480785 2026-03-18

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Zhejiang University

Phase NA Recruiting
780 enrolled
Gynecologic

Leiomyoma, Ovarian Neoplasms, Postoperative Nausea and Vomiting, Gallstones

Data powered by HemOnc (CC BY 4.0) Colophon âš¡